The selling stockholders plan to grant to the underwriters an option to purchase from them an additional 699,615 shares to cover over-allotments, if any.
CardioNet will not be selling any shares of common stock in the offering and will not receive any of the proceeds from the sale of shares by the selling stockholders.
Citi is the sole book-running manager, Banc of America Securities and Leerink Swann are the co-lead managers and Cowen and Company and Thomas Weisel Partners are the co-managers for this offering.